Oncology Grand Rounds Series: Part 2 — Hodgkin and Non-Hodgkin Lymphomas

Video proceedings from the second in a series of 6 integrated symposia held at the 2019 ONS Annual Congress. Featuring perspectives from Dr Christopher R Flowers, Ms Amy Goodrich, Dr Patrick B Johnston and Ms Robin Klebig.

2.1 contact hours

To complete the Post-test and Educational Assessment and Credit Form, click here. A statement of CNE credit will be issued for scores of 80% or better. Your statement of credit will be mailed to you within 3 weeks or may be printed online.

Related links:

Home
CNE evaluation
CNE information and faculty disclosures
Select publications
PowerPoint slides

Introduction
Program overview: Dr Love
Hodgkin Lymphoma (HL)
Case (Ms Klebig): A woman in her early 50s with HL who received up-front brentuximab vedotin with ABVD on a clinical trial and nivolumab after relapse
Case (Ms Goodrich): A man in his mid-50s with relapsed HL who received brentuximab vedotin as a bridge to allogenic transplant
Follicular Lymphoma (FL)
Case (Ms Klebig): A man in his late 50s with multiply relapsed FL who received lenalidomide/rituximab with response and clinical improvement
Case (Ms Goodrich): A man in his late 40s with relapsed FL who received copanlisib
Mantle Cell Lymphoma (MCL)
Case (Ms Goodrich): A man in his early 80s with relapsed MCL and multiple comorbidities who received acalabrutinib
Case (Ms Goodrich): A man in his early 60s who received multiple lines of therapy for relapsed MCL, including venetoclax/rituximab
Diffuse Large B-Cell Lymphoma (DLBCL)
Case (MS Klebig): A woman in her mid-30s with relapsed triple-hit DLBCL who underwent chimeric antigen receptor T-cell therapy
Case (Ms Klebig): A woman in her mid-30s with DLBCL who received CNS prophylaxis with high-dose methotrexate